G. Marconi

siRNA screen identifies QPCT as a druggable target for Huntington's disease

María Jiménez-Sánchez, Wun Lam, Michael Hannus et al. · Nature Chemical Biology · 2015 · 93 citations · Full text

Druggable Target, Genetics, Molecular Biology +2

Exploiting C3-symmetry in the dynamic coordination of a chiral trisoxazoline to copper(ii): improved enantioselectivity, and catalyst stability in asymmetric lewis acid catalysis

C. Foltz, Björn Stecker, G. Marconi et al. · Chemical Communications · 2005 · 88 citations

Asymmetric Catalysis, Chemical Engineering, Dynamic Coordination +12

BACE1 inhibitors: A head group scan on a series of amides

Thomas J. Woltering, Wolfgang Wostl, Hans Hilpert et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 52 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +13

Chiral Arene Ruthenium Complexes. 6. Diastereoselective Formation of Chiral-At-Metal P-Tethered Arene Ruthenium(II) Complexes

Patrı́cia Pinto, G. Marconi, Frank W. Heinemann et al. · Organometallics · 2003 · 48 citations

Materials Science, Inorganic Chemistry, Engineering +12

Stereochemical Consequences of Threefold Symmetry in Asymmetric Catalysis: Distorting <i>C</i>₃ Chiral 1,1,1‐Tris(oxazolinyl)ethanes (“Trisox”) in Cu^II Lewis Acid Catalysts

C. Foltz, Björn Stecker, G. Marconi et al. · Chemistry - A European Journal · 2007 · 43 citations

Chemical Engineering, Lewis Acid Catalysts, Engineering +12